TCF21/POD-1, a Transcritional Regulator of SF-1/NR5A1, as a Potential Prognosis Marker in Adult and Pediatric Adrenocortical Tumors

With recent progress in understanding the pathogenesis of adrenocortical tumors (ACTs), identification of molecular markers to predict their prognosis has become possible. Transcription factor 21 (TCF21)/podocyte-expressed 1 (POD1) is a transcriptional regulatory protein expressed in mesenchymal cel...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Front Endocrinol (Lausanne)
Autori principali: Passaia, Barbara dos Santos, Dias, Matheus Henrique, Kremer, Jean Lucas, Antonini, Sonir Roberto Rauber, de Almeida, Madson Queiroz, Fragoso, Maria Candida Barisson Villares, Lotfi, Claudimara Ferini Pacicco
Natura: Artigo
Lingua:Inglês
Pubblicazione: Frontiers Media S.A. 2018
Soggetti:
Endocrinology
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5827685/
https://ncbi.nlm.nih.gov/pubmed/29520253
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2018.00038
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi